Access evidence for thousands of products
FormularyDecisions is a secure online platform that facilitates the exchange of information between payers and life sciences companies to provide healthcare decision makers with the evidence, resources, and tools to support the product evaluation process. With FormularyDecisions, you can quickly access the information you need on thousands of products all from one site.
FormularyDecisions for payers and HCDM's benefits:
- Streamline the formulary decision making process
- Acquire product information early
- Evaluate competitive evidence
- Understand the US biosimilars market and laws governing every state
- Connect with manufacturers
Enhance the way you gather product data via a single, secure 24/7 platform. There are over 3,000 FDA-approved and pipeline products on the platform.
Start your free registration today.
Start your free registration
Are US payers getting to grips with cost-effectiveness analysis?
Cost-effectiveness analysis (CEA) is widely used in many countries as part of the broader approach to the health technology assessment (HTA) decision process. It’s common in countries with a national or asocial health insurance system where there is a single payer making decisions for the larger population. In the US, with the multi-payer system, the process is more complex and interpretation expertise of CEAs may vary, making CEA utilization among payers limited.
Xcenda’s FormularyDecision team conducted a study to assess the current use of CEAs by US decision-makers, the challenges that they currently face in using CEAs, and the ways in which these could resolved.